Neutralizing Antibody Immune Correlates for a Recombinant Protein Vaccine in the COVAIL Trial is a research paper published in Clinical Infectious Diseases (2024). On theSindex it has a DataRank of 0.251. It has been cited 3 times, with 1 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.208
From this paper's citation signal
Citation Network Contribution
0.0428
From 1 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 1 citer.
National Institute of Allergy and Infectious Diseases
Grant: R37AI054165
National Cancer Institute
Grant: 75N910D00024
National Cancer Institute
Grant: 75N91022F00007
Biomedical Advanced Research and Development Authority
Grant: 75A50122C00008
Biomedical Advanced Research and Development Authority
Grant: 75N93021C00012
Infectious Diseases Clinical Research Consortium
Grant: UM1AI148684
Cerba Research
Grant: 75N93021D00021
US Department of Defense Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense
Grant: W15QKN-16-9-1002
NIAID NIH HHS
Grant: UM1 AI148573
BLRD VA
Grant: I01 BX000207
NIAID NIH HHS
Grant: UM1 AI068614
CSRD VA
Grant: I01 CX002688
NIAID NIH HHS
Grant: UM1 AI068618
NIAID NIH HHS
Grant: UM1 AI068635
NIAID NIH HHS
Grant: UM1 AI148685
CLC NIH HHS
Grant: C0000008
NIH HHS
Sanofi
Department of Health and Human Services
National Institutes of Health
HHS
MeSH Terms
Keywords